Iran vs Nicaragua: The number of people with susceptibility test result for rifampicin
Iran
46.76
in 2021
Nicaragua
46.72
in 2021
Iran rank
116th
Nicaragua rank
117th
The number of people with susceptibility test result for rifampicin over time
- Iran
- Nicaragua
How they compare
Iran currently reports 46.76 against 46.72 in Nicaragua, a difference of 0.04.
The two have swapped places 4 times across 5 shared years of data; in 2017 it was Iran ahead.
Iran ranks 116th and Nicaragua ranks 117th of 146 countries.
Across the 2 decades both report, Iran averaged higher in 1 and Nicaragua in 1.
Head to head by decade
| Decade | Iran | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64 | 44.17 | 19.83 | Iran |
| 2020s | 45.93 | 71.24 | 25.31 | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Iran or Nicaragua?
- Iran, at 46.76 against 46.72 in Nicaragua as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Iran and Nicaragua?
- 0.04, with Iran ahead.
- How many years of comparable data are there for Iran and Nicaragua?
- 5 years are reported by both, from 2017 to 2021.
- How do Iran and Nicaragua rank globally for the number of people with susceptibility test result for rifampicin?
- Iran ranks 116th and Nicaragua ranks 117th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.